Mark Diamond was runner up in the CEO . biotech...

Mark Diamond was runner up in the CEO . biotech Australia..Amongst his peers Mark is respected.
————————

2020 AWARDS (Judges: David Langsam, Marc Sinatra)Chairman of the YearThis award is for those admirals of the fleet who give strategic directions to the captains of their ships. If the objective is unclear, the mission will fail.We are concerned with the gender-bias of the title, but have not found a neutral term for boss of the board. Suggestions are most welcome.
The Board Boss of the Year has been withheld this year, as the contenders are the winners from the past three years: David Williams, Paul Hopper and Sue MacLeman.

CEO of the YearFor the first year in a long time, the final selection was easy. Despite the very long short- list, we took no time to make the judgement.There were many excellent runners-up, including Alcidion’s Kate Quirk, Antisense’s Mark Diamond, Atomo’s John Kelly, Avita’s Dr Mike Perry, Genetic Signatures’ Dr John Melki, Next Science’s Judith Mitchell, Polynovo’s Paul Brennan, Pro Medicus’s Dr Sam Hupert, Proteomics’ Dr Richard Lipscombe and Volpara’s Dr Ralph Highnam. Cochlear’s Dig Howitt, CSL’s Paul Perreault and Resmed’s Mick Farrell all deserve special mentions.

But the 2020 CEO of the Year is unequivocally Telix’s Dr Christian Behrenbruch for dancing on the double-edged sword of so many announcements that we were confused about which was the imaging agent and which was the treatment and unlike some companies we won’t name, didn’t need a trading halt for each and every one.Telix has doubled in market capitalization in 2020 because it has the runs on the board. The company has struck deals and conducted research and development that make it the rising star of Australian biotech. Hell, it even has revenue!Congratulations, Dr Behrenbruch. That will be a glass of shiraz, please.